ANTEOTECH LTD — Board/Management Information 2011

May 15, 2011

==> picture [198 x 108] intentionally omitted <==

16th May 2011

Company’s Announcement Office ASX Limited Exchange Centre 20 Bridge Street Sydney NSW 2000

ASX ANNOUNCEMENT / MEDIA RELEASE Anteo Commences Board Renewal Program

• ADO Appoints Sandra Andersen as Non-Executive Director

• Mr. James Henderson to step down as Non- Executive Chairman

• Mr. Richard Martin to assume role of Interim Chairman while advanced process of identifying further Directors is finalised

Anteo Diagnostics Limited (ASX: ADO) is pleased to announce a number of important changes to the Company’s Board of Directors.

As previously reported, the company plans to strengthen the skills of the Board to ensure ADO has the best leadership team in place to capitalise on the many growth opportunities currently being pursued.

The company is pleased to announce that Sandra (“Sam”) Andersen will join the Board as a Non-Executive Director. Ms. Andersen is a highly experienced senior executive and company director. Most recently, she was the Managing Director of Eyecare Partners Limited, an ASX-listed company with 41 optometry businesses and a staff of 300 people. Sam has also held senior roles in a number of listed technology companies, has held senior executive positions at ANZ, NAB and Commonwealth banks and is well networked within the finance community.

Ms. Andersen is also currently a Non-Executive Director and Chairs the Audit and Risk Committees of Grain Growers Limited, Rural Finance Corporation Limited, and Victorian Rail Track Limited.

Mr. James Henderson has taken the decision to step down as Non-Executive Chairman to pursue his other interests which are requiring him to travel overseas on an increased basis. Mr. Henderson has been pivotal in ADO's success to date, and was instrumental in securing the necessary capital to ensure the company has continued to achieve its growth objectives. The Board is grateful for Mr. Henderson's support and wishes him well in his future endeavours.

Anteo Diagnostics Limited ABN 75 070 028 625

Unit 4, 26 Brandl Street, Eight Mile Plains Qld 4113 Phone 07 3219 0085 Fax 07 3219 0553 Email contact@anteodx.com Web www.anteodx.com

==> picture [198 x 108] intentionally omitted <==

The company is well advanced in its search for additional suitably experienced Directors and, while the process continues, Mr. Richard Martin will assume the role of Interim Chairman.

Mr. Martin commented: "We are delighted to have attracted such an experienced and talented director as Sam Andersen and we are confident she will make a meaningful contribution to Anteo. With our current growth prospects, Sam's experience as both a company director and operational manager in the ASX-listed healthcare sector will add a great deal of value to Anteo.

Sam Andersen added: "Anteo is experiencing an exciting time in its development and I am delighted to be working in a company with significant prospects in the global healthcare sector. I am looking forward to making an active contribution to Anteo in assisting them to achieve their full potential.”

Mr Martin said that the company is looking to appoint up to two additional Directors including one that has extensive experience in a closely aligned healthcare sector. Shareholders will be kept apprised of progress.

ENDS

For More Information Contact Dr Geoff Cumming, CEO Anteo Diagnostics Limited Tel: +61 2 8823 3110

Anteo Diagnostics Limited ABN 75 070 028 625 Unit 4, 26 Brandl Street, Eight Mile Plains Qld 4113 Phone 07 3219 0085 Fax 07 3219 0553 Email contact@anteodx.com Web www.anteodx.com